Immunogenicity and Safety of ChAdOx1 nCoV-19 (AZD1222) as a Homologous Fourth-Dose Booster: A Substudy of the Phase 3 COV003 Trial in Brazil
Costa Clemens SA. et al, (2025), Mayo Clinic Proceedings Innovations Quality and Outcomes, 9
Nipah virus vaccines evaluated in pigs as a 'One Health' approach to protect public health.
McLean RK. et al, (2025), NPJ Vaccines, 10
Age differences in immunity to human seasonal coronaviruses and the immunogenicity of ChAdOx1 nCoV-19 (AZD1222).
Belij-Rammerstorfer S. et al, (2025), EBioMedicine, 118
Translational science at the undergraduate level: awakening talents to overcome the valley of death - case report.
Ferreira RS. et al, (2025), J Venom Anim Toxins Incl Trop Dis, 31